(Q49052349)

18 February 2018

title

Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital. (English)

1 reference

18 February 2018

1 reference

hepatocellular carcinoma

1 reference

8

1 reference

18 February 2018

author name string

Bieke Lambert

1

1 reference

18 February 2018

Emiel Sturm

2

1 reference

18 February 2018

Jeroen Mertens

3

1 reference

18 February 2018

Ruth Oltenfreiter

4

1 reference

18 February 2018

Peter Smeets

5

1 reference

18 February 2018

Roberto Troisi

6

1 reference

18 February 2018

Hans Van Vlierberghe

7

1 reference

18 February 2018

publication date

27 July 2011

1 reference

18 February 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

18 February 2018

volume

38

1 reference

18 February 2018

issue

12

1 reference

18 February 2018

page(s)

2117-2124

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/s00259-011-1881-2

exact match

0 references

cites work

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Resection and liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Novel advancements in the management of hepatocellular carcinoma in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1881-2

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

21 January 2018

1 reference

12 December 2020

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

1 reference

12 December 2020

Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

1 reference

12 December 2020

Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma

1 reference

12 December 2020

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

12 December 2020

10.1007/S00259-011-1881-2

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018